US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-22 06:30:46 Source：Culture Corner news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
- Previous：Elvis' granddaughter Riley Keough fights Graceland estate auction
- Next：What to expect in the California 20th District special election
Related articles
- No more cute snaps of Mt Fuji. A screen is up in a Japanese town to prevent tourist crowds
- The View's Whoopi Goldberg reveals her daughter got pregnant at the age of 15 as 'REVENGE'
- China's Xi arrives in Hungary for talks on expanding Chinese investments
- Airbnb shares slide on lower revenue forecast despite a doubling of net income
- At least 6 Egyptian women die after vehicle slides off ferry and plunges into Nile River
- Teoscar Hernández hits 2
- Florida deputies who fatally shot US airman burst into wrong apartment, attorney says
- Why Blake Lively and Ryan Reynolds skipped the Met Gala for the SECOND year in a row
- Guardians ruin Francisco Lindor's Cleveland homecoming, trip Mets 3
- Lionel Messi's Inter Miami named the 18th
- Warner holds out IPL hot shot Fraser
- Rangers reacquire OF Robbie Grossman in trade with White Sox
- Court rules North Carolina Catholic school could fire gay teacher who announced his wedding online
- Plastic surgeons reveal which Met Gala celebs they think may be using Ozempic
- Pogacar extends Giro lead to over 7 minutes after winning altered Stage 16 amid protests at start
- Dramatic moment cruise passenger is airlifted from 1,000ft Carnival Venezia in 'life
- Kenya's public hospital doctors sign agreement to end national strike after almost 2 months
- AstraZeneca pulls COVID vaccine from European market
- Wayne Bennett, at 74, signs a 3
- How Kim Kardashian's breathtaking silver corset proves the dangerous centuries
Random recommendation
- Copyright © 2024 Powered by US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition ,Culture Corner news portal sitemap